Sale is live|00:00:00

Denali Therapeutics Inc. Common Stock

DNLI

Biotechnology: Biological Products (No Diagnostic Substances)

$20.95

Market Cap

$3M

P/E Ratio

Revenue Rank

Margin Rank

Earnings Analysis Coming Soon

We're processing earnings call transcripts for this company. Check back soon for AI-powered insights.

Explore More Tools

Discover more ways to research and analyze Indian stocks